Monotherapy for Rheumatoid Arthritis: Leveraging the Latest Evidence to Treat to Target

In this downloadable slideset, Jonathan Scott Coblyn, MD; Jessica Farrell, PharmD; and Frances Griffin, RN, BSN, provide an overview of best practices in the use of monotherapy to treat rheumatoid arthritis.
Jonathan Scott Coblyn, MD
Program Director
Jessica Farrell, PharmD
Frances Griffin, RN, BSN
Format: Microsoft PowerPoint (.ppt)
File Size: 346 KB
Released: June 29, 2018

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Pfizer

Related Content

Expert slides from Clinical Care Options (CCO) on optimal management of inflammatory bowel disease (IBD), including ulcerative colitis, Crohn disease

Uma Mahadevan, MD William Sandborn, MD Released: September 22, 2020

A review on how new and emerging data in the management of atopic dermatitis will affect clinical practice: atopic dermatitis conference coverage from CCO

Andrew F. Alexis, MD, MPH Jonathan Silverberg, MD Released: September 21, 2020

Expert commentary reviewing FDA-approved biologic therapeutics for type 2 asthma

Eileen Wang, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: September 21, 2020 Expired: September 20, 2021

Expert commentary on real-world and trial data on treating RA after failing biologic and targeted small-molecule DMARDs, from EULAR 2020 by CCO

Eric M. Ruderman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: August 27, 2020 Expired: August 26, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue